# Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery

> **NCT05063370** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 40 (actual)

## Conditions studied

- Right Heart Failure
- Open-heart Surgery

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Standard Care

## Key facts

- **NCT ID:** NCT05063370
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-18
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063370, "Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05063370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*